AtriCure Inc

For the period ended Dec 31, 2024. Filed Feb 14, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 14, 2025

ATRC$56.26-2.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations and Comprehensive Loss

YEARS ENDED DECEMBER 31, 2024, 2023 and 2022

	2024	2023	2022
Revenue	$465,307	$399,245	$330,379
Cost of revenue	117,783	98,875	84,439
Gross profit	347,524	300,370	245,940
Operating expenses:
Research and development expenses	96,178	73,915	57,337
Selling, general and administrative expenses	291,359	253,138	231,272
Total operating expenses	387,537	327,053	288,609
Loss from operations	(40,013)	(26,683)	(42,669)
Other income (expense):
Interest expense	(6,407)	(6,925)	(4,986)
Interest income	4,434	3,792	1,994
Loss on debt extinguishment	(1,362)	—	—
Other	(326)	(31)	(537)
Loss before income tax expense	(43,674)	(29,847)	(46,198)
Income tax expense	1,024	591	268
Net loss	$(44,698)	$(30,438)	$(46,466)
Net loss per share:
Basic and diluted net loss per share	$(0.95)	$(0.66)	$(1.02)
Weighted average shares outstanding - basic and diluted	46,965	46,309	45,740
Comprehensive (loss) income:
Unrealized gain (loss) on investments	$800	$2,898	$(2,811)
Foreign currency translation adjustment	(842)	205	(337)
Other comprehensive (loss) income	(42)	3,103	(3,148)
Net loss	(44,698)	(30,438)	(46,466)
Comprehensive loss, net of tax	$(44,740)	$(27,335)	$(49,614)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.